Wave expects to initiate a Phase 2a multidose portion of WVE-007 INLIGHT clinical trial in individuals living with obesity with higher BMI and ...

PTC Therapeutics, Inc. today provided an update on the Company's progress and its outlook for 2026. Matthew B. Klein, M.D., Chief Executive Officer of PTC, will discuss these updates at the Company's ...

Most of the original Israeli investors - mainly OrbiMed and Pontifax Venture Capital - exited around the IPO, and as far as ...

The firm's share price fell after a presentation at the conference revealed lower-than-expected Elevidys sales.

Qure N.V. (NASDAQ:QURE) surged around 15% in early trading on Friday after the company said it has secured a Type A meeting ...

Among the funded activities for older Vermonters are arts workshops in Wolcott, creative circus arts in Island Pond and Newport, multi-week visual arts programming at senior centers in Burlington, ...

Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today announced its new five-year strategy, "Alnylam ...

Detailed price information for Wave Life Sci Ord Sh (WVE-Q) from The Globe and Mail including charting and trades.